WuXi AppTec (2359.HK): Continuation of the Uptrend

WuXi AppTec (2359), a pharmaceutical company, jumped 7% yesterday as investors chased the technology stock after Nasdaq marked a new record high. After the outbreak of coronavirus, health technology is one of the strongest sectors in the Hong Kong Market.

Uptrend 1

WuXi AppTec (2359), a pharmaceutical company, jumped 7% yesterday as investors chased the technology stock after Nasdaq marked a new record high. After the outbreak of coronavirus, health technology is one of the strongest sectors in the Hong Kong Market.

The company soared around 85% from March low, while the Hang Seng Index was only up 18%. The performance of the company is outperforming.

Recently, the company reported that 2Q adjusted net income jumped 43.1% on year to 942 million yuan on operating revenue of 4.04 billion yuan, up 29.4%.

Besides, the company was rated "new buy" at Jefferies with target prices at HK$145.

From a technical point of view, the stock is supported by a rising trend line drawn from May on a daily chart. In addition, the RSI is also riding above the bullish trend line drawn from March. In addition, the prices have recorded a series of higher tops and higher bottoms since March low.

Bullish readers could consider placing the nearest support level at HK$104, while the resistance levels would be located at HK$130.2 (100% measured move) and HK$136.7 (127.2% measured move).


Source: GAIN Capital, TradingView

Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.